| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d5f917ef303b5a805f1fbe476d95396f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5bbcc101da8b0a6a87bb2fa1e934ae8c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2799-022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate |
1997-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91f6ba3eea96348939400f8dc57a279e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_324dbbb891bf7baf8085ac721a9e6a42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fdbecae6ea3e602cacbbe7283cae844
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee65a62d1cf279f94a0b5b93bbfe5312 |
| publicationDate |
2001-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
NZ-334508-A |
| titleOfInvention |
Use of a polynucleotide that encodes a VEGF145 in treating cardiovascular disease |
| abstract |
A polynucleotide that encodes a VEGF145 is used in the manufacture of a medicament for treating cardiovascular disease in a mammal wherein the treatment comprises that step of transfecting cells of the mammal with the medicament. VEGF145 is used in the manufacture of a medicament for treating vascular disease or for enhancing endothelialization of diseased vessels in a mammal. Also disclosed are an expression vector containing VEGF145 or a biologically active fragment and a therapeutic composition containing VEGF145 and a pharmaceutically acceptable carrier. A polynucleotide sequence encoding a VEGF145 species identified as SEQ ID 1 or a biologically active fragment is disclosed. |
| priorityDate |
1996-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |